Autopsy report · NCT01709136

Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Sirolimus usage discontinued since black box warning”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 years 6 months after it had already started.
Ran for about 4 years 1 month before it stopped.
3 participants enrolled.
Results were posted on the registry 6 years 3 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2, Phase 3
Sponsor: University of Pittsburgh
Sponsor type: University, hospital or other
Conditions: Hypertension
Interventions: Sirolimus
Participants: 3

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.